In a recent phase II trial, researchers further investigated the potential long-term benefits of aggressive local treatment in patients with unresectable colorectal liver metastases.
In a recent study, researchers compared the safety, efficacy, and tolerability of 2 treatment combinations for patients with non-small cell lung cancer with brain metastases. To see results of the study,...
After results from a recent trial demonstrated its efficacy, the FDA expanded the indication of a cancer drug to include adult patients with chronic graft versus host disease who do not respond to other...
The FDA granted accelerated approval to a new treatment for adolescent and adult patients with mismatch repair deficient and microsatellite instability metastatic colorectal cancer.
Although melanoma is still the deadliest form of skin cancer, squamous cell carcinoma is now much more common and can be fatal, according to a new study.
In a recent study, researchers evaluated the association between renal transplantation and risk of melanoma. Also evaluated were other risk factors for developing melanoma in this patient population.
The Cancer Genome Atlas project recently discovered 4 molecular subtypes of gastric cancer. In a recent study, researchers sought to determine the clinical significance of these subtypes and how they affect...
In a recent study, researchers tested the safety and efficacy of a treatment combination for women with advanced breast cancer who experienced disease progression while receiving endocrine therapy. To see...
A recent study assessed the efficacy of atezolizumab across different lines of therapy in patients with advanced non-small cell lung cancer. For study results, including the objective response rate after 12...
The FDA has expanded the approval of an intravenous injection for the treatment of metastatic or unresectable melanoma to include use in pediatric patients.
